Atenolol for prevention of preeclampsia.
Ellis
M R
MR
University of Missouri, Columbia, USA.
Kane
K Y
KY
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D001724:Birth Weight; D002302:Cardiac Output; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011225:Pre-Eclampsia / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second / Q000502:physiology; D011254:Pregnancy in Diabetics / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012307:Risk Factors
D000959:Antihypertensive Agents; D001262:Atenolol